Man Group plc Sells 2,111 Shares of Chemed Co. (NYSE:CHE)

Man Group plc trimmed its position in shares of Chemed Co. (NYSE:CHE) by 6.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,667 shares of the company’s stock after selling 2,111 shares during the quarter. Man Group plc owned 0.20% of Chemed worth $16,247,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nomura Holdings Inc. purchased a new stake in shares of Chemed in the 4th quarter worth $1,053,000. Nuveen Asset Management LLC increased its stake in shares of Chemed by 18.0% in the 4th quarter. Nuveen Asset Management LLC now owns 39,451 shares of the company’s stock worth $20,901,000 after purchasing an additional 6,005 shares in the last quarter. Occudo Quantitative Strategies LP increased its stake in shares of Chemed by 214.1% in the 4th quarter. Occudo Quantitative Strategies LP now owns 1,652 shares of the company’s stock worth $875,000 after purchasing an additional 1,126 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Chemed by 16.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,358 shares of the company’s stock worth $1,779,000 after purchasing an additional 482 shares in the last quarter. Finally, Lazard Asset Management LLC increased its stake in shares of Chemed by 245.4% in the 4th quarter. Lazard Asset Management LLC now owns 10,166 shares of the company’s stock worth $5,385,000 after purchasing an additional 7,223 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CHE shares. Royal Bank of Canada upped their price objective on Chemed from $667.00 to $674.00 and gave the stock an “outperform” rating in a research note on Monday, April 28th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.

Chemed Stock Performance

Shares of CHE stock opened at $579.48 on Friday. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61. The firm has a market capitalization of $8.48 billion, a PE ratio of 29.28, a PEG ratio of 2.15 and a beta of 0.59. The stock has a fifty day simple moving average of $586.22 and a two-hundred day simple moving average of $564.20.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. During the same quarter in the prior year, the business posted $5.20 EPS. Chemed’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, sell-side analysts forecast that Chemed Co. will post 21.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Spencer S. Lee sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the completion of the transaction, the executive vice president now owns 16,127 shares in the company, valued at $9,319,148.22. This trade represents a 8.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the firm’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now owns 101,679 shares of the company’s stock, valued at approximately $62,566,139.07. The trade was a 0.97% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,000 shares of company stock worth $3,534,135. Corporate insiders own 3.29% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.